AYAKO SUGIYAMA: Open Payments
NPI 1871128157 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 130 payments from 18 companies in 2025. Trend: 2023 $1,551 · 2024 $1,794 · 2025 $2,158
Food & beverage: $2,158
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $448 |
| Lundbeck LLC | 16 | $300 |
| E.R. Squibb & Sons, L.L.C. | 14 | $291 |
| Vanda Pharmaceuticals Inc. | 14 | $259 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $214 |
| Otsuka America Pharmaceutical, Inc. | 11 | $136 |
| Corium, LLC | 5 | $98 |
| Axsome Therapeutics, Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
Products named: VRAYLAR, REXULTI, COBENFY, FANAPT, CAPLYTA, Azstarys, Auvelity, SPRAVATO.
Industry payments across TX — which companies pay providers there.
